Literature DB >> 30560443

Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells.

Rozaina Ahmad1, Noor Haida Mohd Kaus2, Shahrul Hamid3.   

Abstract

INTRODUCTION: Drug resistance has been a continuous challenge in cancer treatment. The use of nanotechnology in the development of new cancer drugs has potential. One of the extensively studied compounds is thymoquinone (TQ), and this work aims to compare two types of TQ-nanoformulation and its cytotoxicity toward resistant breast cancer cells.
METHOD: TQ-nanoparticles were prepared and optimized by using two different formulations with different drugs to PLGA-PEG ratio (1:20 and 1:7) and different PLGA-PEG to Pluronic F68 ratio (10:1 and 2:1). The morphology and size were determined using TEM and DLS. Characterization of particles was done using UV-VIS, ATR-IR, entrapment efficiency, and drug release. The effects of drug, polymer, and surfactants were compared between the two formulations. Cytotoxicity assay was performed using MTS assay.
RESULTS: TEM finding showed 96% of particles produced with 1:7 drug to PLGA-PEG were less than 90 nm in size and spherical in shape. This was confirmed with DLS which showed smaller particle size than those formed with 1:20 drug to PLGA-PEG ratio. Further analysis showed zeta potential was negatively charged which could facilitate cellular uptake as reported previously. In addition, PDI value was less than 0.1 in both formulations indicating monodispersed and less broad in size distribution. The absorption peak of PLGA-PEG-TQ-Nps was at 255 nm. The 1:7 drug to polymer formulation was selected for further analysis where the entrapment efficiency was 79.9% and in vitro drug release showed a maximum release of TQ of 50%. Cytotoxicity result showed IC50 of TQ-nanoparticle at 20.05 μM and free TQ was 8.25 μM.
CONCLUSION: This study showed that nanoparticle synthesized with 1:7 drug to PLGA-PEG ratio and 2:1 PLGA-PEG to Pluronic F68 formed nanoparticles with less than 100 nm and had spherical shape as confirmed with DLS. This could facilitate its transportation and absorption to reach its target. There was conserved TQ stability as exhibited slow release of this volatile oil. The TQ-nanoparticles showed selective cytotoxic effect toward UACC 732 cells compared to MCF-7 breast cancer cells.

Entities:  

Keywords:  Breast cancer; Drug resistance; Nanoparticle; Thymoquinone

Mesh:

Substances:

Year:  2020        PMID: 30560443     DOI: 10.1007/5584_2018_302

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

Review 1.  Injectable Hydrogels for Localized Cancer Therapy.

Authors:  Dao-Yang Fan; Yun Tian; Zhong-Jun Liu
Journal:  Front Chem       Date:  2019-10-11       Impact factor: 5.221

Review 2.  Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis.

Authors:  Ravi Raj Pal; Vasundhara Rajpal; Priya Singh; Shubhini A Saraf
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

Review 3.  Plant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy.

Authors:  Saikat Dewanjee; Pratik Chakraborty; Biswajit Mukherjee; Vincenzo De Feo
Journal:  Int J Mol Sci       Date:  2020-03-23       Impact factor: 5.923

4.  Long Non-coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis.

Authors:  Rongfeng Qu; Chunmei Hu; Yan Tang; Qiong Yu; Guang Shi
Journal:  Cancer Manag Res       Date:  2020-03-10       Impact factor: 3.989

Review 5.  Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review.

Authors:  Naif A Al-Gabri; Sultan A M Saghir; Sallah A Al-Hashedi; Ali H El-Far; Asmaa F Khafaga; Ayman A Swelum; Abdullah S Al-Wajeeh; Shaker A Mousa; Mohamed E Abd El-Hack; Mohammed A E Naiel; Khaled A El-Tarabily
Journal:  Int J Nanomedicine       Date:  2021-07-27

6.  Thymoquinone-Loaded Chitosan Nanoparticles as Natural Preservative Agent in Cosmetic Products.

Authors:  María Mondéjar-López; Alberto José López-Jiménez; Joaquín C García Martínez; Oussama Ahrazem; Lourdes Gómez-Gómez; Enrique Niza
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.